hovid-Telmisartan Tablet 40mg

Country: Malaysia

Bahasa: Inggeris

Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

Bahan aktif:

TELMISARTAN

Boleh didapati daripada:

HOVID BERHAD

INN (Nama Antarabangsa):

TELMISARTAN

Unit dalam pakej:

3x10 Tablets

Dikeluarkan oleh:

Jubilant Generics Limited

Risalah maklumat

_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP) _
HOVID-TELMISARTAN TABLET
Telmisartan 40mg and 80mg
1
WHAT IS IN THIS LEAFLET
1.
What Telmisartan tablet is used for
2.
How Telmisartan tablet works
3.
Before you use Telmisartan tablet
4.
How to use Telmisartan tablet
5.
While
you
are
using
Telmisartan
tablet
6.
Side effects
7.
Storage
and
Disposal
of
Telmisartan tablet
8.
Product description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of revision
WHAT TELMISARTAN TABLET IS USED FOR
Telmisartan
tablet
is
used
to
treat
essential
hypertension
(high
blood
pressure).
‘Essential’
means
that
the
high blood pressure is not caused by
any other condition.
High blood pressure, if not treated, can
damage blood vessels in several organs,
which
could
lead
sometimes
to
heart
attack, heart or kidney failure, stroke, or
blindness.
There
are
usually
no
symptoms of high blood pressure before
damage occurs. Thus it is important to
regularly
measure
blood
pressure
to
verify if it is within the normal range.
Telmisartan tablet is also used to reduce
cardiovascular events (i.e. heart attack
or stroke) in patients who are at risk
because they have a reduced or blocked
blood supply to the heart or legs, or
have
had
a
stroke
or
have
high
risk
diabetes. Your doctor can tell you if you
are at high risk for such events.
HOW TELMISARTAN TABLET WORKS
Telmisartan tablet belongs to a class of
medicines
known
as
angiotensin
II
receptor antagonists. Angiotensin II is a
substance produced in your body which
causes
your blood vessels to narrow,
thus increasing your blood pressure.
Telmisartan tablet blocks the effect of
angiotensin II so that the blood vessels
relax, and thus the blood pressure is
lowered.
BEFORE YOU USE TELMISARTAN TABLET
_- When you must not use it _
Do not take this medicine if you:

are allergic to telmisartan or any of
the excipients.

are more than 3 months pregnant. (It
is better to avoid telmisartan during
pregnancy altogether)

are
lactating
as
it
is
not
known
whether
telmisartan
is
excreted
in
hu

Ciri produk

Telmisartan
can
be
used
in
additional
to
other
needed
treatment
(such
as
antihypertensive, antiplatelet or lipid-lowering therapy). Consider
using the ACE
inhibitor first, and, if it is stopped for cough only, consider
re-trying the ACE inhibitor
after the cough resolves.
Use of telmisartan with an ACE inhibitor is not recommended.
CONTRAINDICATION
•
Hypersensitivity to the active substance or to any excipients used.
•
Second and third trimesters of pregnancy
•
Biliary obstructive disorders
•
Severe hepatic impairment
•
Concomitant
use
of
telmisartan
with
aliskiren-containing
products
is
contraindicated in patients with diabetes mellitus or renal impairment
(GFR < 60
ml/min/1.73m
2
).
•
Telmisartan is contraindicated during lactation since it is not known
whether it is
excreted in human milk. Animal studies have shown excretion of
telmisartan in
breast milk.
WARNINGS AND PRECAUTIONS
PREGNANCY
Angiotensin II receptor antagonists should not be initiated during
pregnancy. Unless
continued angiotensin II receptor antagonist therapy is considered
essential,
patients planning pregnancy should be changed to alternative
antihypertensive
treatments which have an established safety profile for use in
pregnancy. When
pregnancy is diagnosed, treatment with angiotensin II receptor
antagonists should
be stopped immediately, and, if appropriate, alternative therapy
should be started.
HEPATIC IMPAIRMENT
Telmisartan is not to be given to patients with cholestasis, biliary
obstructive
disorders or severe hepatic impairment since telmisartan is mostly
eliminated with
the bile. These patients can be expected to have reduced hepatic
clearance for
telmisartan.
Telmisartan should be used only with caution in patients with mild to
moderate
hepatic impairment.
RENOVASCULAR HYPERTENSION
There is an increased risk of severe hypotension and renal
insufficiency when
patients with bilateral renal artery stenosis or stenosis of the
artery to a single
functioning
kidney
are
treated
with
medicinal
products
that
affect
the
renin-angio